The impact of recipient HLA-Cw and donor killer immunoglobulin-like receptor genotyping on the outcome of patients receiving HLA-matched sibling donor haematopoietic stem cell transplantation for myeloid malignancies. Swiss Med Wkly [Internet]. 2012 Dec. 30 [cited 2025 Oct. 15];143(0102):w13717. Available from: https://www.smw.ch/index.php/smw/article/view/1806